D. E. Shaw & Co., Inc. Matinas Bio Pharma Holdings, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$0.59 - $0.9 $16,225 - $24,750	-27,500 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$0.79 - $1.11 $9,586 - $13,469	-12,135 Reduced 30.62%	27,500 $24,000
Q1 2019 May 15, 2019	SELL	$0.6 - $1.41 $2,679 - $6,295	-4,465 Reduced 10.12%	39,635 $43,000
Q4 2018 Feb 14, 2019	BUY	$0.53 - $1.11 $23,373 - $48,951	44,100 New	44,100 $26,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.